Product Categories
| Country: | United States |
|---|---|
| Tel: | 781-+1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | info@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36 Washington Street, Wellesley Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| MA242 | C26H21ClF3N3O5S | 1049704-18-8 | Details |
| MAC13772 | C8H9N3O3S | 4871-40-3 | Details |
| Macitentan-d4；ACT-064992 D4;Macitentan D4 | C19H16Br2D4N6O4S | 1258428-05-5 | Details |
| Macitentan (n-butyl analogue) | C20H21Br2N5O4S | 556797-16-1 | Details |
| Macropa-NCS | C27H35N5O8S | 2146095-31-8 | Details |
| m-Tyramine | C8H11NO | 588-05-6 | Details |
| m-Tyramine hydrobromide | C8H12BrNO | 38449-59-1 | Details |
| MAGL-IN-1 | C22H24FNO3 | 2324160-91-8 | Details |
| Malic enzyme inhibitor ME1；ME1 | C20H21N3O3 | 522649-59-8 | Details |
| Manitimus；FK778 | C15H11F3N2O2 | 202057-76-9 | Details |
| MAP4K4-IN-3；Compound 17 | C15H12ClN5 | 1811510-58-3 | Details |
| MAPK13-IN-1 | C20H23N5O2 | 229002-10-2 | Details |
| Maritoclax；Marinopyrrole A | C22H12Cl4N2O4 | 1227962-62-0 | Details |
| MARK-IN-1 | C22H23F2N7OS | 1109283-93-3 | Details |
| MARK-IN-2 | C18H18ClF2N5OS | 1314893-26-9 | Details |
| Masupirdine free base；SUVN-502 free base | C21H24BrN3O3S | 701205-60-9 | Details |
| Masupirdine mesylate；SUVN-502 mesylate | C22H28BrN3O6S2 | 1791396-46-7 | Details |
| MAT2A inhibitor 2 | C18H24ClN3O3 | 13299-99-5 | Details |
| Mavoglurant racemate；AFQ-056 racemate | C19H23NO3 | 1636881-61-2 | Details |
| Mavoglurant；AFQ056 | C19H23NO3 | 543906-09-8 | Details |
| MB-07344 | C19H25O5P | 852947-39-8 | Details |
| MB-07729 | C12H15N2O5PS | 882755-95-5 | Details |
| MBC-11 | C11H20N3O14P3 | 332863-86-2 | Details |
| MBC-11 trisodium | C11H21N3NaO14P3 | 387877-45-4 | Details |
| MBM-17 | C28H28N6O2 | 2083621-90-1 | Details |
| MBM-17S | C32H34N6O6 | 2083621-91-2 | Details |
| MBM-55 | C28H27FN6O2 | 2083622-09-5 | Details |
| MBM-55S | C32H33FN6O6 | 2083624-07-9 | Details |
| MCB-3681 | C31H32F2N4O8 | 790704-42-6 | Details |
| MCH-1 antagonist 1 | C25H26N4O2 | 1039825-68-7 | Details |
| MCHR1 antagonist 3 | C29H36N4O2 | 1069622-60-1 | Details |
| MCHR1 antagonist 2 | C23H21FN2O5 | 863115-70-2 | Details |
| Mcl-1 antagonist 1 | C41H54ClF2N5O8S | 2376775-05-0 | Details |
| MCL-1/BCL-2-IN-2 | C20H15BrN2O2S | 2163793-44-8 | Details |
| Trimebutine maleate；Polibutin;Debridat | C26H33NO9 | 34140-59-5 | Details |
| MCL-1/BCL-2-IN-3 | C27H25BrN2O5S | 2163793-55-1 | Details |
| MCL-1/BCL-2-IN-4 | C26H23BrN2O5S | 2163793-56-2 | Details |
| Mcl-1 inhibitor 3 | C40H52ClF2N5O7S | 2376774-73-9 | Details |
| Mcl1-IN-11 | C38H41N3O5S2 | 2042211-13-0 | Details |
| Mcl1-IN-12 | C45H46N4O6S2 | 2042211-12-9 | Details |
| PROTAC Mcl1 degrader-1 | C45H45BrN6O8S | 2163793-38-0 | Details |
| Mcl1-IN-4 | C28H26N2O5S | 1580484-04-3 | Details |
| Mcl1-IN-9 | C37H39ClN4O4 | 1810769-31-3 | Details |
| McN3716；Methyl palmoxirate;NSC359682 | C18H34O3 | 69207-52-9 | Details |
| McN5691；RWJ26240 | C30H35NO3 | 99254-95-2 | Details |
| Tetracaine hydrochloride；Amethocalne HCl;Amethocaine hydrochloride;Tetracaine HCl | C15H25ClN2O2 | 136-47-0 | Details |
| MD-224 | C48H43Cl2FN6O6 | 2136247-12-4 | Details |
| MDL 19301 | C15H21NS2 | 89388-38-5 | Details |
| MDM2-IN-1 | C23H21Cl2FN2O3 | 1410737-09-5 | Details |
| MDRTB-IN-1 | C15H18N2O3 | 1973401-05-6 | Details |
| Mebeverine acid D5 | C16H25NO3 | 2070015-30-2 | Details |
| Mebeverine D6 Hydrochloride | C25H36ClNO5 | 1329647-20-2 | Details |
| Mebeverine acid；Mebeverine metabolite Mebeverine acid | C16H25NO3 | 475203-77-1 | Details |
| Mebeverine alcohol；Mebeverine metabolite Mebeverine alcohol | C16H27NO2 | 14367-47-6 | Details |
| O-desmethyl Mebeverine acid；Mebeverine metabolite O-desmethyl Mebeverine acid | C15H23NO3 | 586357-02-0 | Details |
| O-Desmethyl Mebeverine alcohol；Mebeverine metabolite O-desmethyl Mebeverine alcohol | C15H25NO2 | 155172-67-1 | Details |
| Mitotane；Mitotan;o,p'-DDD;2,4′-DDD;NCI-C04933 | C14H10Cl4 | 53-19-0 | Details |
| Meclofenamic acid；Meclofenamate | C14H11Cl2NO2 | 644-62-2 | Details |
| Mefentrifluconazole | C18H15ClF3N3O2 | 1417782-03-6 | Details |
| Mefuparib hydrochloride；MPH | C17H16ClFN2O2 | 1449746-00-2 | Details |
| MEK inhibitor | C26H26N4O2 | 334951-92-7 | Details |
| Melagatran | C22H31N5O4 | 159776-70-2 | Details |
| Melatonin-d4；N-Acetyl-5-methoxytryptamine D5;Melatonin D5 | C13H12D4N2O2 | 66521-38-8 | Details |
| MELK-8a hydrochloride | C25H33ClN6O | 2096992-20-8 | Details |
| MELK-IN-1；MELK inhibitor 17;Nintedanib Impurity L | C31H33N5O4 | 2095596-44-2 | Details |
| Meloxicam-d3；Meloxicam D4 | C14H13N3O4S2 | 942047-63-4 | Details |
| Meluadrine tartrate | C16H24ClNO8 | 134865-37-5 | Details |
| MEN11467 | C38H40N4O3 | 214487-46-4 | Details |
| Menaquinone-7；Vitamin K2(35);Vitamin K2-7;Vitamin MK-7 | C46H64O2 | 2124-57-4 | Details |
| Menin-MLL inhibitor 4 | C32H38FN7O3 | 2169916-13-4 | Details |
| Mensacarcin | C21H24O9 | 808750-39-2 | Details |
| Meropenem trihydrate；SM 7338 trihydrate | C17H27N3O6S | 119478-56-7 | Details |
| meta-Fexofenadine；meta-MDL-16455;meta-Terfenadine carboxylate | C32H39NO4 | 479035-75-1 | Details |
| Metarrestin；ML246 | C31H30N4O | 1443414-10-5 | Details |
| MethADP sodium salt | C11H18N5NaO9P2 | 89016-30-8 | Details |
| MethADP；Adenosine 5'-(α,β-methylene)diphosphate | C11H17N5O9P2 | 3768-14-7 | Details |
| Telomerase-IN-1 | C21H23FN2O4 | 666859-49-0 | Details |
| Sulpiride；Aiglonyl;Dobren;Dolmatil;Sulpyrid;Dogmatil | C15H23N3O4S | 15676-16-1 | Details |
| Aurora B inhibitor 1 | C25H26ClF2N7O2 | 937276-52-3 | Details |
| Methimazole D3 | C4H6N2S | 1160932-07-9 | Details |
| Methoxy-PEPy | C13H10N2O | 524924-76-3 | Details |
| Methyl 3-O-methylgallate；M3OMG | C9H10O5 | 3934-86-9 | Details |
| Methyl carnosate | C21H30O4 | 82684-06-8 | Details |
| Methyl homoveratrate | C11H14O4 | 15964-79-1 | Details |
| Methyl L-pyroglutamate；L-Pyroglutamic acid methyl ester;(S)-Methyl 5-oxopyrrolidine-2-carboxylate | C6H9NO3 | 4931-66-2 | Details |
| Methyllycaconitine citrate；MLA | C43H58N2O17 | 351344-10-0 | Details |
| Methylnaltrexone-d3 bromide；Methylnaltrexone D3 Bromide | C21H26BrNO4 | 1131456-47-7 | Details |
| Methylproamine | C28H31N7 | 188247-01-0 | Details |
| Cotinine；S-(-)-Cotinine;(-)-Cotinine;(S)-Cotinine;NIH-10498 | C10H12N2O | 486-56-6 | Details |
| Metixene hydrochloride | C20H23NS.ClH | 1553-34-0 | Details |
| Metofenazate；Methophenazine | C31H36ClN3O5S | 388-51-2 | Details |
| Metronidazole Benzoate；Benzoyl metronidazole | C13H13N3O4 | 13182-89-3 | Details |
| Mexiletine-d6 hydrochloride；KOE-1173 D6 hydrochloride;Mexiletine D6 hydrochloride | C11H18ClNO | 1329835-60-0 | Details |
| MF-094 | C30H37N3O4S | 2241025-68-1 | Details |
| MF 5137 | C23H23N3O3 | 148927-23-5 | Details |
| MGAT2-IN-1 | C27H21ClF5N7O3S | 1800025-30-2 | Details |
| Nadolol；SQ11725;Solgol;Corgard;Anabet | C17H27NO4 | 42200-33-9 | Details |
| MGAT2-IN-2 | C26H21F5N4O4S | 1710630-11-7 | Details |
| MG 1 | C17H25N3O2 | 148274-76-4 | Details |
| MFZ 10-7 hydrochloride | C15H10ClFN2 | 1779796-36-9 | Details |
| Product Total： Product Page： | ||||
| 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 | ||||